Sekar Kathiresan
CIK 1864112 · Chief Executive Officer · last filed 2025-09-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
22
Lifetime Open-Market Net
-$11.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-16 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-05 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | — | -$1.61M | EDGAR |
| 2022-08-11 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | — | -$1.43M | EDGAR |
| 2022-07-27 | RLAY | Grant (A) | — | $0 | EDGAR |
| 2022-07-21 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | — | -$1.43M | EDGAR |
| 2022-07-15 | Verve Therapeutics, Inc. (VERV) Delisted | Gift (G) | — | $0 | EDGAR |
| 2022-03-22 | Verve Therapeutics, Inc. (VERV) Delisted | Exer (M) | +69,674 | $200.0K | EDGAR |
| 2022-02-15 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-06 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | — | -$72.0K | EDGAR |
| 2021-12-29 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | — | -$1.89M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.